Column Group II GP, LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 128,626 shares at $17.89 ($2.3M) on 2020-08-13, disclosed to the SEC on 2020-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.89 | 19,895 | $356K | 15.7% |
| 2 | $17.89 | 19,895 | $356K | 15.7% |
| 3 | $17.49 | 37,993 | $664K | 29.3% |
| 4 | $17.49 | 37,993 | $664K | 29.3% |
| 5 | $17.89 | 6,425 | $115K | 5.1% |
| 6 | $17.89 | 6,425 |
| $115K |
| 5.1% |
| Total | $17.65 avg | 128,626 | $2.3M | 100% |
| Filing → |
| NGM | BUY | 2019-07-15 | $885K | — | Filing → |
| NGM | BUY | 2019-05-09 | $804K | — | Filing → |
| IMDZ | BUY | 2016-09-22 | $5.0M | — | Filing → |